CSIMarket
 


Anixa Biosciences Inc   (ANIX)
Other Ticker:  
 
 

ANIX's Revenue Growth by Quarter and Year

Anixa Biosciences Inc 's Revenue results by quarter and year




ANIX Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter October - 0.00 0.00 0.00
III Quarter July - 0.21 0.00 0.00
II Quarter April - 0.00 0.00 0.51
I Quarter January 0.00 0.51 0.00 0.00
FY   0.00 0.72 0.00 0.51



ANIX Revenue first quarter 2024 Y/Y Growth Comment
Anixa Biosciences Inc in the first quarter 2024 recorded of $ 0.00 millions.

According to the results reported in the first quarter 2024, Anixa Biosciences Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Anixa Biosciences Inc ' s Revenue no change of % ranks overall at the positon no. in the first quarter 2024.




ANIX Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY   - - - -

Financial Statements
Anixa Biosciences Inc 's first quarter 2024 Revenue $ 0.00 millions ANIX's Income Statement
Anixa Biosciences Inc 's first quarter 2023 Revenue $ 0.51 millions Quarterly ANIX's Income Statement
New: More ANIX's historic Revenue Growth >>


ANIX Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY (Year on Year)   - - - -




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Anixa Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ANIX's I. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ANIX's I. Quarter Q/Q Revenue Comment


Anixa Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jan 31 2024)
12 Months Ending
(Jul 31 2023)
12 Months Ending
(Apr 30 2023)
12 Months Ending
(Jan 31 2023)
12 Months Ending
(Oct 31 2022)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Jan 31 2024 period, Anixa Biosciences Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Anixa Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jan 31 2024 period, Anixa Biosciences Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Anixa Biosciences Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ANIX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for ANIX's Competitors
Revenue Growth for Anixa Biosciences Inc 's Suppliers
Revenue Growth for ANIX's Customers

You may also want to know
ANIX's Annual Growth Rates ANIX's Profitability Ratios ANIX's Asset Turnover Ratio ANIX's Dividend Growth
ANIX's Roe ANIX's Valuation Ratios ANIX's Financial Strength Ratios ANIX's Dividend Payout Ratio
ANIX's Roa ANIX's Inventory Turnover Ratio ANIX's Growth Rates ANIX's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Jan 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jan 31 2024
Champions Oncology Inc -5.90%$ -5.903 millions
Avid Bioservices Inc -12.19%$ -12.192 millions
Kewaunee Scientific Corporation-24.32%$ -24.321 millions
Lakeland Industries Inc -43.84%$ -43.837 millions
Enzo Biochem Inc-47.65%$ -47.650 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com